Toxins News and Research

RSS

Gladstone-led study finds underlying mechanisms behind Huntington's disease

Alzheimer's, Huntington's, Parkinson's. Names forever linked to what they represent: diseases that ravage the brain's neurons and leave entire regions to wither and die. These and other so-called neurodegenerative diseases are often associated with the buildup of toxic proteins that lead to the death of neurons.

22 Jul 2013

C. difficile bacteriophage provides new weapon to battle against superbugs

IFR microbiologists are reinvigorating a way of battling C. difficile infections that they hope will help overcome the growing problem of antibiotic resistant superbugs in hospitals.

19 Jul 2013

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier and kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).

19 Jul 2013

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Aquavit Pharmaceuticals, Inc. announces it has signed a definitive licensing agreement with U-Bio Med Inc., a medical technology device company in South Korea, for the worldwide commercialization of the company's microneedle device technology.

19 Jul 2013

Safe Life FZC employs NanoSeptic self-cleaning products to combat MERS outbreak

Safe Life FZC, a new breed of healthcare distributors based in United Arab Emirates, is employing the latest technology to combat dangerous outbreaks like the deadly Coronavirus or MERS (Middle East Respiratory Syndrome).

18 Jul 2013

Study shows environmental conditions have stronger influence on human microbiome

Environmental conditions have a much stronger influence on the mix of microbes living in various parts of your body than does competition between species. Instead of excluding each other, microbes that fiercely compete for similar resources are more likely to cohabit the same individual.

17 Jul 2013

Researchers develop new test to detect E. coli at food processing facilities

Medical, agriculture and computer science researchers from the University of Alberta have teamed up to develop a test that will make Canadians feel safer about the meat they put on their tables.

16 Jul 2013

Ipsen closes acquisition of UK-based Syntaxin

Ipsen announced today the closing of the acquisition of Syntaxin, a UK-based private life sciences company specialized in botulinum toxin engineering.

15 Jul 2013

Infrared light allows characterization of pathogens

The bacterium Staphylococcus aureus (S. aureus) is commonly found in nature and frequently colonizes the skin and the upper respiratory tract of humans. A healthy immune system can fight the microorganism but once the immune system is weakened the pathogen can spread and lead to life-threatening diseases of the lungs, the heart and other organs.

15 Jul 2013

Ipsen, Harvard initiate collaboration to discover, develop botulinum toxins for neurologic diseases

Ipsen announced today that it has initiated a research and development collaboration on novel engineered botulinum toxins with Harvard Medical School.

15 Jul 2013

Researcher uncover biomarkers from stem cells derived from bone marrow of ALS patients

Amyotrophic Lateral Sclerosis (ALS) is a devastating motor neuron disease that rapidly atrophies the muscles, leading to complete paralysis. Despite its high profile - established when it afflicted the New York Yankees' Lou Gehrig - ALS remains a disease that scientists are unable to predict, prevent, or cure.

10 Jul 2013

Codex Alimentarius Commission approves new standards to protect consumers' health

The UN food standards body Codex Alimentarius has agreed on new standards to protect the health of consumers worldwide. These include standards on fruit, vegetables, fish and fishery products and animal feed.

9 Jul 2013

Adverse fetal growth, exposure to maternal smoking correlated with lower measures of sperm quality

Studies over the past 20 years have suggested (though not unequivocally confirmed) that semen quality is in decline, reflected most evidently in falling sperm counts and reduced sperm motility.

8 Jul 2013

Low levels of amyloid fibres are more harmful to health, say scientists

Neurodegenerative diseases such as Alzheimer's could be better understood thanks to insight into proteins linked to such conditions, a study suggests.

2 Jul 2013

Scientists discover new mechanism to protect body from harmful bacteria

Scientists at the University of Calgary's Faculty of Medicine have discovered a mechanism that is used to protect the body from harmful bacteria. Platelets, a component of blood typically associated with clotting, were discovered to actively search for specific bacteria, and upon detection, seal it off from the rest of the body. The findings, which were published in Nature Immunology this week, provide the science community with a greater understanding of immunity.

19 Jun 2013

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Genmab A/S and ADC Therapeutics Sarl, announced today an agreement to develop a new antibody-drug conjugate product combining Genmab's HuMax-TAC antibody and ADC Therapeutics' PBD-based warhead and linker technology.

17 Jun 2013

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Ambrx and Zhejiang Medicine Co. Ltd. today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate targeting Her2-positive breast cancer.

17 Jun 2013

Study shows smoking in entrances to bars, restaurants increases concentration of nicotine

The protection provided by the smoking ban decreases when people can still smoke outside the venue For the first time, a study has analysed the effects of the modification to the Spanish tobacco control law, implemented in 2011 in hospitality venues in Spain.

15 Jun 2013

Johns Hopkins researchers develop experimental vaccine for TB meningitis

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in adults with compromised immune system.

12 Jun 2013

New analytical techniques show certain foodstuffs exceed permitted levels of mycotoxins

Researchers from the University of Granada (Spain) have analysed the presence of patulin, a type of toxin produced by fungi, in several commercial apple juices. The results show that more than 50% of the samples analysed exceed the maximum limits laid down by law.

10 Jun 2013

Toxins News and Research

Gladstone-led study finds underlying mechanisms behind Huntington's disease

C. difficile bacteriophage provides new weapon to battle against superbugs

Nanotechnology drug kills brain-tumor cells and retards growth of tumor blood vessels

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Safe Life FZC employs NanoSeptic self-cleaning products to combat MERS outbreak

Study shows environmental conditions have stronger influence on human microbiome

Researchers develop new test to detect E. coli at food processing facilities

Ipsen closes acquisition of UK-based Syntaxin

Infrared light allows characterization of pathogens

Ipsen, Harvard initiate collaboration to discover, develop botulinum toxins for neurologic diseases

Researcher uncover biomarkers from stem cells derived from bone marrow of ALS patients

Codex Alimentarius Commission approves new standards to protect consumers' health

Adverse fetal growth, exposure to maternal smoking correlated with lower measures of sperm quality

Low levels of amyloid fibres are more harmful to health, say scientists

Scientists discover new mechanism to protect body from harmful bacteria

Genmab, ADC Therapeutics agree to develop new antibody-drug conjugate product

Ambrx, ZMC partner to develop and commercialize ARX788 for treatment of Her2-positive breast cancer

Study shows smoking in entrances to bars, restaurants increases concentration of nicotine

Johns Hopkins researchers develop experimental vaccine for TB meningitis

New analytical techniques show certain foodstuffs exceed permitted levels of mycotoxins

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News